Cardiac Dimensions has treated the first patient in a clinical trial of its carillon mitral contour system, a novel therapy for treating heart failure patients suffering from functional mitral regurgitation.

The mitral contour system consists of a proprietary, implantable device with a percutaneous catheter delivery system.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The one-year, follow-up, prospective, single-arm Titan II clinical trial is intended to further evaluate an enhanced version of the carillon system as a treatment for heart failure.

The initial 53-patient Titan trial demonstrated relief from functional mitral regurgitation and improvements in functional capacity and quality of life compared to a contemporaneously-enrolled control group.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact